Levosalbutamol & Ipratropium Bromide Inhalation - DUOZEST Inhaler

DUOZEST Inhaler
Composition:- Levo Salbutamol 50mcg + Ipratropium Bromide 20mcg

DUOZEST Inhaler – The Levosalbutamol & Ipratropium Bromide Inhalation combines Levosalbutamol 50 mcg and Ipratropium Bromide 20 mcg to provide rapid and sustained relief in obstructive airway conditions. Levosalbutamol, a selective β2 agonist, relaxes bronchial smooth muscles to relieve bronchospasm quickly. Ipratropium, an anticholinergic agent, reduces mucus secretion and prevents airway constriction, offering prolonged bronchodilation.

Key Points of Levosalbutamol & Ipratropium Bromide Inhalation – DUOZEST Inhaler
• Dual Bronchodilator Effect – Levosalbutamol provides rapid β2-mediated bronchodilation, while Ipratropium offers anticholinergic bronchodilation, enhancing airflow and easing symptoms.
• Effective in Acute Exacerbations – Helps manage sudden bronchospasm, asthma attacks, and COPD flare-ups by targeting multiple airway pathways.
• Minimal Systemic Side Effects – Inhalation delivers localized therapy, reducing systemic exposure and making it safer for children, adults, and elderly patients.

Can be Prescribed by:
• Pulmonologists
• General Physicians
• Pediatricians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.